Insider holders · CIK 0001720893
BioXcel Therapeutics, Inc. · BTAI
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Krishnan NandabalanDirector | 1,000 | 9,480,000 | 9,481,000 | Nov 30, 2018 · 4:17 pm EST | Form 4 |
| BioXcel Corp10% Owner | 9,480,000 | — | 9,480,000 | Mar 7, 2018 · 6:24 pm EST | Form 3 |
| Vimal MehtaCEO and President | 69,817 | 480,343 | 550,160 | Jun 17, 2026 · 8:00 pm EDT | Form 4 |
| Peter MuellerDirector | 158,320 | — | 158,320 | Dec 7, 2018 · 5:50 pm EST | Form 4 |
| Javier RodriguezSee Remarks | 26,838 | — | 26,838 | Jun 17, 2026 · 8:01 pm EDT | Form 4 |
| Richard I SteinhartChief Financial Officer | 26,335 | — | 26,335 | Jun 17, 2026 · 8:00 pm EDT | Form 4 |
| Frank YoccaChief Scientific Officer | 26,210 | — | 26,210 | Jun 17, 2026 · 8:00 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.